November 2012

Abbott's board approves pharma split ()
Ex-cath lab tech indicted in Hep-C outbreak ()
CCTA bests angio for undetected lesions ()
FDA: Ranbaxy suspends atorvastatin production ()
Bracco issues Class I recall of Isovue injector syringes ()
Case not closed: Inpatient-outpatient conundrum ()
AFFIRM analysis questions digoxin’s safety ()
St. Jude's Assura ICD, CRT-Ds net EU approval ()
Study: Warfarin’s benefits extend to six months after valve surgery ()
2 HF studies challenge clinical trial findings ()
Merit nabs GE's catheter-based device maker for $167M ()
Phone-letter prompts improve first-time statin adherence ()
Atrial fibrillation associated with higher rates of sudden cardiac death ()
Ranbaxy recalls atorvastatin tablets ()
Sorin invests $5.4M in percutaneous mitral valve developer ()
Volcano buys cath imaging firm ()
Coding changes on the horizon ()
Preparing for value-based payment ()
Survival advantage maintains for EVAR vs. open repair, but choice isn't clear-cut ()
Florida hospitals pay $10M to settle CV suit ()
Anticoagulant apixaban gets nod for stroke prevention in EU ()
Simple model predicts risk of stent thrombosis, but is it necessary? ()
Abiomed investors file civil suit, seeking jury trial ()
FDA lists “inadequacies” at St. Jude facility ()
Unemployment associated with higher risk of MI ()
FDA approves HeartWare’s bridge-to-transplant system ()
Xarelto approved for PE, DVT uses in Europe ()
First year after stroke is associated with highest hospital costs ()
Societies advise tailored approach to stable ischemic heart disease ()
Employed medical directors pull in less pay than independents ()
Using EHRs + snail mail nudges up statin prescriptions ()
HeartSine issues Class I recall of defibrillators ()
St. Jude scores EU approval of Portico transcatheter aortic heart valve ()
‘Good medical practice’ explains discord in STEMI studies ()
More evidence on older women, newer cancer drugs ()
CDC: Median diabetes prevalence in U.S increases 82.2% over 15 years ()
FDA approves first DES to treat PAD ()
Time to tackle wasteful practices ()
Simplifying admin tasks could save $29K per doc annually ()
Survival rates for in-hospital cardiac arrest climb ()
Boehringer recalls one lot of Pradaxa ()
Edwards wins THV patent duel with Medtronic ()
Lower-extremity amputation varies significantly by region ()
FDA expands indication for Medtronic's stent graft ()
P4P: Brits tweak U.S. model + find success ()
Survey shows cardiologists dour about future ()
Doc handoff procedures may favor patients at start of list ()
Societies offer guidance on troponin testing ()
FDA green-lights Cordis vascular stent for SFA, PPA ()
Only one-third of cardiac meeting abstracts get published ()
Metformin may be better choice than sulfonylurea for diabetics ()
CBO: Keeping physician fees as is aids GDP ()
AHA: Cell therapy offers no short-term benefit post-STEMI ()
AHA: Both allogeneic, autologous stem cells safe and effective ()
FDA clears Ocelot catheter for PAD ()
AHA: Diuretic-based therapy superior to ultrafiltration in HF patients ()
Boston Sci reaches into renal denervation market with $425M Vessix buy ()
Hail to all who add to the evidence base ()
Impella nets Category I CPT codes for 2013 ()
AHA: Monoclonal antibody drug reduces LDL-C levels in statin-intolerant patients ()
AHA: Patients benefit with changes in ICD programming ()
AHA: Drug raises HDL levels but fails to reduce ACS risk ()
AHA: Platelet reactivity is not predictive of ischemic outcomes ()
AHA: PCI is more costly than CABG for diabetics with advanced CAD in the long run ()
Subcutaneous ICD study details initial experiences ()
AHA: No evidence fish oil prevents AF in postsurgical patients ()
AHA: Elective PCIs cost more at hospitals with no onsite cardiac surgery ()
AHA: Aspirin’s latest laurel: Preventing recurrent venous thromboembolism ()
AHA: CABG bests PCI for diabetics with multivessel disease, but not for stroke ()
AHA: Bedside platelet monitoring offers no improvement in outcomes ()
FDA expands Xarelto's indication for DVT, PE ()
Carrel takes helm of AtriCure ()
CMS fee schedule favors PCPs, and cardiologists face cuts ()
FDA: No more bleeds with new use of dabigatran ()
No gender differences in long-term MI outcomes ()
AHA sues HHS over rescinded pay for services, like caths ()
TCT.12: Miami sun shines light on clinical gray zones ()
Nurses Take Point in CV Care ()
Rx for Getting Patients to Follow Doctors’ Orders ()
Take 18 Pills & Call the Nurse in the Morning ()
How Long Can We Go? Duration of In-hospital Resuscitation ()
Benchmarking: Cardiologists’ Ally in Tough Times ()
Seeking Tools for Best Practices in Cardiac Care ()
Prescribing Benefit, Risk to Drug Sales Reps ()
Transforming Cardiac Care One EKG at a Time ()
Song of Silence: Making Alarms’ Din Manageable ()